Cardiovascular Risk Factors in a Patient with Diabetes Mellitus and Coronary Artery Disease: Therapeutic Approaches to Improve Outcomes: Perspectives of a Preventive Cardiologist

被引:31
作者
Davidson, Michael H. [1 ]
机构
[1] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
关键词
NON-HDL CHOLESTEROL; EXENATIDE TWICE; BLOOD-PRESSURE; TYPE-2; PIOGLITAZONE; METAANALYSIS; EVENTS; SAFETY; ASSOCIATION; INHIBITORS;
D O I
10.1016/j.amjcard.2012.08.033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In patients with diabetes mellitus (DM), a cardiovascular event is of critical concern because of the impact on long-term survival. Cardiovascular disease (CVD) is the leading cause of death for patients with DM, which makes the modification of risk factors in the patient with DM and CVD a primary focus of the preventive cardiologist. Management of this patient population should include pharmacologic interventions, such as antidyslipidemics (mainly statins) and oral anti-DM (or insulin) agents, as well as diet control, physical exercise, and smoking cessation. It is hoped that focus on the ABCs of treatment-hemoglobin A(1c), blood pressure, and cholesterol-lipid profile-along with ongoing and future studies on the effects of these interventions will help to reduce the significant morbidity and mortality from microvascular and macrovascular complications in these high-risk patients with DM. (C) 2012 Elsevier Inc. All rights reserved. (Am J Cardiol 2012;110[suppl]:43B-49B)
引用
收藏
页码:43B / 49B
页数:7
相关论文
共 32 条
[1]  
Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc12-s011]
[2]  
[Anonymous], DIABETOLOGIA S1
[3]  
[Anonymous], DIAB NUMB AT A GLANC
[4]   Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies A retrospective analysis of the LifeLink database [J].
Best, Jennie H. ;
Hoogwerf, Byron J. ;
Herman, William H. ;
Pelletier, Elise M. ;
Smith, Daniel B. ;
Wenten, Made ;
Hussein, Mohamed A. .
DIABETES CARE, 2011, 34 (01) :90-95
[5]   Association of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins A Meta-analysis [J].
Boekholdt, S. Matthijs ;
Arsenault, Benoit J. ;
Mora, Samia ;
Pedersen, Terje R. ;
LaRosa, John C. ;
Nestel, Paul J. ;
Simes, R. John ;
Durrington, Paul ;
Hitman, Graham A. ;
Welch, K. M. A. ;
DeMicco, David A. ;
Zwinderman, Aeilko H. ;
Clearfield, Michael B. ;
Downs, John R. ;
Tonkin, Andrew M. ;
Colhoun, Helen M. ;
Gotto, Antonio M., Jr. ;
Ridker, Paul M. ;
Kastelein, John J. P. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (12) :1302-1309
[6]   Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6) [J].
Buse, John B. ;
Rosenstock, Julio ;
Sesti, Giorgio ;
Schmidt, Wolfgang E. ;
Montanya, Eduard ;
Brett, Jason H. ;
Zychma, Marcin ;
Blonde, Lawrence .
LANCET, 2009, 374 (9683) :39-47
[7]   The Prospective Pioglitazone Clinical Trial in Macrovascuar Events (PROactive) - Can ploglitazone reduce cardiovascular events in diabetes? - Study design and baseline characteristics of 5,238 patients [J].
Charbonnel, B ;
Dormandy, J ;
Erdmann, E ;
Massi-Benedetti, M ;
Skene, A .
DIABETES CARE, 2004, 27 (07) :1647-1653
[8]   A meta-analysis comparing the effect of thiazolidinediones on cardiovascular risk factors [J].
Chiquette, E ;
Ramirez, G ;
DeFronzo, R .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (19) :2097-2104
[9]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[10]   Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1 [J].
Crajoinas, Renato O. ;
Oricchio, Felipe T. ;
Pessoa, Thaissa D. ;
Pacheco, Bruna P. M. ;
Lessa, Lucilia M. A. ;
Malnic, Gerhard ;
Girardi, Adriana C. C. .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2011, 301 (02) :F355-F363